Clinical trial
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.
NCT04273932 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.
- Lead sponsor
- State University of New York at Buffalo
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 17, 2019
- Completion date
- August 12, 2023
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.